<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="hwp">eLife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">27402</article-id><article-id pub-id-type="doi">10.7554/eLife.27402</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Biochemistry and Chemical Biology</subject></subj-group></article-categories><title-group><article-title>Characterisation of the biflavonoid hinokiflavone as a pre-mRNA splicing modulator that inhibits SENP</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-85069"><name><surname>Pawellek</surname><given-names>Andrea</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-85070"><name><surname>Ryder</surname><given-names>Ursula</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-85071"><name><surname>Tammsalu</surname><given-names>Triin</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-85072"><name><surname>King</surname><given-names>Lewis J</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="par-6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-85073"><name><surname>Kreinin</surname><given-names>Helmi</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="par-7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-8326"><name><surname>Ly</surname><given-names>Tony</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-21172"><name><surname>Hay</surname><given-names>Ronald T</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-3"/><xref ref-type="other" rid="par-4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-85074"><name><surname>Hartley</surname><given-names>Richard</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-4118"><name><surname>Lamond</surname><given-names>Angus I</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-6204-6045</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">Centre for Gene Regulation and Expression, School of Life Sciences</institution>, <institution>University of Dundee</institution>, <addr-line><named-content content-type="city">Dundee</named-content></addr-line>, <country>United Kingdom</country></aff><aff id="aff2"><institution>WestCHEM School of Chemistry, University of Glasgow</institution>, <addr-line><named-content content-type="city">Glasgow</named-content></addr-line>, <country>United Kingdom</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-10209"><name><surname>Valcárcel</surname><given-names>Juan</given-names></name><role>Reviewing editor</role><aff><institution>Centre de Regulació Genòmica (CRG), Barcelona</institution>, <country>Spain</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>a.i.lamond@dundee.ac.uk</email> (AL);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>08</day><month>09</month><year>2017</year></pub-date><volume>6</volume><elocation-id>e27402</elocation-id><history><date date-type="received"><day>02</day><month>04</month><year>2017</year></date><date date-type="accepted"><day>06</day><month>09</month><year>2017</year></date></history><permissions><copyright-statement>© 2017, Pawellek et al</copyright-statement><copyright-year>2017</copyright-year><copyright-holder>Pawellek et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-27402-v1.pdf"/><abstract><p>We have identified the plant biflavonoid hinokiflavone as an inhibitor of splicing <italic>in vitro</italic> and modulator of alternative splicing in cells. Chemical synthesis confirms hinokiflavone is the active molecule. Hinokiflavone inhibits splicing<italic> in vitro</italic> by blocking spliceosome assembly, leading to accumulation of the A complex. Cells treated with hinokiflavone show altered subnuclear organization specifically of splicing factors required for A complex formation, which relocalize together with SUMO1 and SUMO2 into enlarged nuclear speckles. Hinokiflavone increases protein SUMOylation levels, both in <italic>in vitro</italic> splicing reactions and in cells. Hinokiflavone also inhibited a purified, <italic>E. coli</italic> expressed SUMO protease, SENP1, <italic>in vitro</italic>, indicating the increase in SUMOylated proteins results primarily from inhibition of de-SUMOylation. Using a quantitative proteomics assay we identified many SUMO2 sites whose levels increased in cells following hinokiflavone treatment, with the major targets including 6 proteins that are components of the U2 snRNP and required for A complex formation.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>None</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100010269</institution-id><institution>Wellcome</institution></institution-wrap></funding-source><award-id>073980/Z/03/B</award-id><principal-award-recipient><name><surname>Lamond</surname><given-names>Angus I</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100010269</institution-id><institution>Wellcome</institution></institution-wrap></funding-source><award-id>097045/B/11/Z</award-id><principal-award-recipient><name><surname>Lamond</surname><given-names>Angus I</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100010269</institution-id><institution>Wellcome</institution></institution-wrap></funding-source><award-id>098391/Z/12/7</award-id><principal-award-recipient><name><surname>Hay</surname><given-names>Ronald T</given-names></name></principal-award-recipient></award-group><award-group id="par-4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100010269</institution-id><institution>Wellcome</institution></institution-wrap></funding-source><award-id>105606/Z/14/Z</award-id><principal-award-recipient><name><surname>Hay</surname><given-names>Ronald T</given-names></name></principal-award-recipient></award-group><award-group id="par-5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000780</institution-id><institution>European Commission</institution></institution-wrap></funding-source><award-id>PITN-GA-2011-290257</award-id><principal-award-recipient><name><surname>Tammsalu</surname><given-names>Triin</given-names></name></principal-award-recipient></award-group><award-group id="par-6"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000266</institution-id><institution>Engineering and Physical Sciences Research Council</institution></institution-wrap></funding-source><award-id>EP/L50497X/1</award-id><principal-award-recipient><name><surname>King</surname><given-names>Lewis J</given-names></name></principal-award-recipient></award-group><award-group id="par-7"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000266</institution-id><institution>Engineering and Physical Sciences Research Council</institution></institution-wrap></funding-source><award-id>EP/L50497X/1</award-id><principal-award-recipient><name><surname>Kreinin</surname><given-names>Helmi</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="datasets"><title>Major datasets</title><p/><p>The following datasets were generated:</p><p><related-object content-type="generated-dataset" id="dataro1" source-id="https://www.ebi.ac.uk/pride/archive/projects/PXD007629" source-id-type="uri"><collab>Pawellek A</collab>, <collab>Tammsalu T</collab>, <collab>Hay RT</collab>, <collab>Lamond AI</collab>, <year>2017</year><x>,</x> <source>Characterisation of the biflavonoid hinokiflavone as a pre-mRNA splicing modulator that inhibits SENP</source><x>,</x> <ext-link ext-link-type="uri" xlink:href="https://www.ebi.ac.uk/pride/archive/projects/PXD007629">https://www.ebi.ac.uk/pride/archive/projects/PXD007629</ext-link><x>,</x> <comment>Publicly available at PRIDE (accession no. PXD007629)</comment></related-object></p></sec><supplementary-material><ext-link xlink:href="elife-27402-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>